Patents by Inventor Paul R. Klink

Paul R. Klink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tilmicosin formulation
    Patent number: 5574020
    Abstract: An aqueous, injectable, sustained release tilmicosin formulation comprises 250-350 mg/ml of tilmicosin and 250 mg/ml of propylene glycol, and has a pH adjusted to 6.
    Type: Grant
    Filed: January 13, 1995
    Date of Patent: November 12, 1996
    Assignee: Eli Lilly and Company
    Inventors: Paul R. Klink, Thomas D. Thomson